Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Depressive disorders

Efficacy and tolerability of 21 antidepressants in the acute setting.

    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
  • 2 minute read

Depressive disorders are among the most common, burdensome, and costly mental illnesses in adults worldwide. In addition to psychotherapy, antidepressants are a central therapeutic component in the treatment of depression. An international review of the use of the most commonly prescribed antidepressants.

Background: An estimated 350 million people worldwide suffer from depression. Thus, depressive disorders are among the most common, burdensome, and costly mental illnesses in adults worldwide. This raises the question of how affected individuals can best be helped. In addition to psychotherapy, antidepressants are a central therapeutic component in the treatment of depression. In order to prescribe the most effective antidepressants to patients, physicians rely on extensive clinical research in this area. The efficacy of different antidepressants has already been compared in clinical trials, but until now there was no overview of the most commonly prescribed antidepressant medications and their side effects.

Investigation: The international study presented here was the first to demonstrate the efficacy as well as  tolerability of the most commonly prescribed antidepressants in the acute treatment of adults with depressive disorder. The meta-analysis reviewed all available research on 21 first- or second-generation antidepressants. In total, the findings from 522 double-blind studies conducted between 1979 and 2016 were compiled and analyzed. The surveys include information from 116,477 patients. Findings from 522 clinical trials provide a solid basis for using antidepressants more effectively. Antidepressants were tested against either another antidepressant agent or placebo. In the studies, the researchers set the period of intake at eight weeks. The percentage of patients whose depressive symptoms were reduced by at least 50 percent was surveyed. Treatment subjects were randomly assigned to an antidepressant or randomized to placebo.

Results: In terms of antidepressant efficacy, it was apparent that all 21 antidepressants studied were better at relieving symptoms of depression than placebo. However, antidepressants differed among themselves in efficacy and tolerability. Amitriptyline, mirtazapine, and duloxetine showed the best results in terms of efficacy. The relative efficacy of antidepressants compared with placebo was also demonstrated for remission. From the meta-analysis, the administration of agomelatine and fluoxetine was associated with fewer antidepressant treatment discontinuations than placebo therapy, implying good tolerability of the two antidepressants. Subjects randomly assigned to antidepressant treatment who discontinued the study because of side effects showed a higher withdrawal rate than subjects assigned to placebo. Considering efficacy and tolerability together, the researchers demonstrated that some antidepressants had a better relationship between depressive symptom reduction and side effects. Thus, these antidepressants work better and, at the same time, antidepressant treatment is discontinued less frequently due to side effects.

Conclusions: Overall, all antidepressants studied were better at relieving symptoms of depression than placebo. A caveat, however, is that the antidepressant agents can cause side effects that led some individuals to discontinue treatment. Not all subjects could benefit from antidepressant treatment. The meta-analysis presented here can be used to assist in making the first choice for pharmacological treatment of acute depressive disorders in adults and thus makes an important contribution to the optimal treatment of acute depression.

 

InFo NEUROLOGY & PSYCHIATRY 2018; 16(2): 35.

Autoren
  • Carole Kaufmann
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • Amitriptyline
  • Antidepressants
  • Depression
  • Effectiveness
  • Fluoxetine
  • Mirtazapine
Previous Article
  • Developmental Psychology

The doctor-patient relationship from the perspective of attachment theory

  • Education
  • Psychiatry and psychotherapy
  • RX
View Post
Next Article
  • SGPP Annual Congress 2017, Bern - video lecture

Video: General intervention principles for the treatment of borderline personality disorder.

  • Congress Reports
  • Psychiatry and psychotherapy
  • RX
  • Training with partner
View Post
You May Also Like
View Post
  • 10 min
  • Electrolyte disturbance

Hyponatremia in the outpatient setting

    • CME continuing education
    • General Internal Medicine
    • Hematology
    • Nephrology
    • RX
    • Studies
    • Urology
View Post
  • 16 min
  • Pain and autism

Hurdles to pain treatment for autistic patients

    • CME continuing education
    • Pediatrics
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Chronic musculoskeletal pain

How can the use of analgesics be optimized in multimodal therapy?

    • Congress Reports
    • General Internal Medicine
    • Orthopedics
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Case study

Opportunistic infection by Serratia marcescens

    • Cases
    • Education
    • General Internal Medicine
    • Infectiology
    • Pneumology
    • RX
View Post
  • 6 min
  • Interview with Prof. Thomas Kündig (USZ)

“If we control itching and eczema, a normal life is possible again”

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Interviews
    • Partner Content
    • RX
View Post
  • 3 min
  • From symptom to diagnosis

Abdominal pain – groin pain: internal causes

    • Cases
    • Education
    • Gynecology
    • Radiology
    • RX
    • Surgery
    • Urology
View Post
  • 2 min
  • Chronic pain

Nano-ECS modulator Adezunap improves therapy success

    • Congress Reports
    • General Internal Medicine
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Rheumatology
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis and PsA

Biologics, oral peptide and trivalent nanobody – current results and trends

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Hyponatremia in the outpatient setting
  • 2
    Hurdles to pain treatment for autistic patients
  • 3
    How combination therapies lead to better treatment results
  • 4
    Interplay between cancer and mental illness
  • 5
    PH and lung diseases

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.